VORAPAXAR | VORAPAXAR | ATC B01AC26
BLOOD PROTEASE-ACTIVATED RECEPTOR-1 (PAR-1) ANTAGONIST REDUCTION OF THROMBOTIC CARDIOVASCULAR EVENTS INHIBITOR OF PLATELET AGGREGATION ITS LONG HALF-LIFE MAKES IT EFFECTIVELY IRREVERSIBLE | ORAL | Tmax 1 HOUR F 100 PERCENT VD 424 LITER PPB 99 PERCENT Cl 1.5 LITER / HOUR (EQN) HT 192 HOUR SOLUBILITY SLIGHTLY SOLUBLE IN WATER AT PH 1 | PROTEASE-ACTIVATED RECEPTOR-1 (PAR-1) PDB 3VW7 (CRYSTAL STRUCTURE OF HUMAN PROTEASE-ACTIVATED RECEPTOR 1 (PAR1) BOUND WITH ANTAGONIST VORAPAXAR AT 2.2 ANGSTROM) LIGAND CODE = VPX (link to the list of PDB complexes) Download experimental 3D coordinates of VPX with added hydrogens | PROTEINASE-ACTIVATED RECEPTOR 1 ANTAGONIST CHEMBL3974 PROTEINASE-ACTIVATED RECEPTOR 1 P25116 PROTEINASE-ACTIVATED RECEPTOR 1 HOMO SAPIENS MEMBRANE RECEPTOR 7TM1 PEPTIDE PROTEASE-ACTIVATED RECEPTOR PROTEASE-ACTIVATED RECEPTOR | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |